Atilano, Charie Joy D.
HRN: 10-42-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/26/2022
CEFUROXIME 1.5GM (VIAL)
09/26/2022
10/02/2022
IV
1.5g
Q8
Tibial Fracture
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes